In this study, eighteen monoclonal antibodies (MAbs) to recent Japanese encephalitis virus (JEV) genotype I were produced and characterized by plaque reduction neutralization test, western blot analysis, indirect immunofluorescence assay and enzyme-linked immunosorbent assay. All MAbs recognized only envelope (E) protein or conformational epitope of E and precursor membrane proteins. Two MAbs (7E5 and 3-3H8) possessed virus-neutralization activity, and their escape mutants possessed a change of glutamine to histidine at the position of 52 of E protein, suggesting that these neutralizing MAbs recognize the domain I-II hinge region of E protein. Five MAbs recognized all examined flaviviruses, and two were specific to JEV. These MAbs may be useful for differentiation and diagnosis of flaviviruses.
Japanese encephalitis virus (JEV) is a member of genus
Flavivirus, family Flaviviridae. JEV is transmitted primarily by Culex tritaeniorhynchus vector mosquitoes, and pigs play a main role as amplifiers. The virus is widely endemic in nations of Southeast Asia and the Western Pacific, including Japan [10] , with an annual incidence of approximately 50,000 cases and 10,000 deaths in humans [3] .
Many methods have been used for serological survey of JEV in various animals, such as plaque reduction neutralization test (PRNT), hemagglutination inhibition (HI) assay and enzyme-linked immunosorbent assay (ELISA). Among them, PRNT is currently "gold standard" for the serological differentiation of flavivirus infections [11] . However, to perform PRNT using live JEV, a special facility, biosafety level 2 and high level of technical skill are required. Also, a large volume of serum samples is required to perform either PRNT or HI assay. In contrast, ELISA does not require the use of live virus and the procedure is simple, and requires only a small amount of serum samples. We and other laboratories have reported the usability of indirect IgG ELISA for serological survey of JEV [2, 4, 14, [21] [22] [23] . Although indirect ELISA allows us to examine a large number of samples at once, the crossreactivity of the antibody with other flaviviruses obstructs us to perform the JEV-specific diagnosis. Since dengue virus (DENV) and JEV have overlapped geographic distributions in several countries in Southeast Asia [10] , diagnostic tools to differentiate JEV from other flaviviruses are required.
In Asia including Japan, a main genotype of JEV has changed from genotype III to I since 1990's [1, 9, 13, 17] . Although there is a report that antigenicity between genotypes I and III is different [18] , the difference of antigenicity among JEV genotypes has been obscure. Furthermore, many monoclonal antibodies (MAbs) to JEV were reported and have been used as diagnostic and research tools, but there is no MAb to JEV genotype I. In this study, MAbs to recent JEV genotype I were produced, and the specificities were compared among various flaviviruses.
BALB/c mice (5 weeks old, male) were intraperitoneally immunized with JEV/sw/Chiba/88/2002 3 or 4 times at intervals of three weeks. The mice were euthanized 3 to 7 days after the final immunization, and the splenocytes were fused with P3U1 myeloma cells by using 50% polyethylene glycol solution (Hybri-Max TM ; Sigma-Aldrich, St. Louis, MO, U.S.A.). The hybridoma cells were diluted in selection media, GIT media (Wako, Osaka, Japan) containing 2% hypoxanthine-aminopterin-thymidine (HAT) supplement (GIBCO, Grand Island, NY, U.S.A.), 10% BM-condimed H1 hybridoma cloning supplement (Roche Diagnostics, Mannheim, Germany) and 10% FCS, and incubated for 7 to 10 days at 37°C and 5% CO 2 . The screening of hybridomas was performed by either PRNT or indirect immunofluorescence assay (IFA) using JEV/sw/Chiba/88/2002. PRNT was carried out as described previously [16, [19] [20] [21] . For IFA, fluorescein-conjugated goat anti-mouse IgM+IgG+IgA (Southern Biotech, Birmingham, AL, U.S.A.) was used as a secondary antibody.
Total of 18 hybridomas were finally isolated and intraperitoneally injected into pristane-treated BALB/c mice (5 weeks old, male) to produce ascites. The immunoglobulin subclass of MAbs was determined using an IsoStrip mouse monoclonal antibody isotyping kit (Roche Applied Science, *CorrespondenCe to: Maeda, K., Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan. e-mail: kmaeda@yamaguchi-u.ac.jp ©2013 The Japanese Society of Veterinary Science Mannheim, Germany) according to the manufacturer's instructions. The heavy chain subclasses of MAbs are shown in Table 1 , and their light chains were all kappa isotype.
To determine the protein recognized by MAbs, plasmids expressing precursor membrane (prM) and/or envelope (E) proteins were constructed. RT-PCR was carried out from JEV/sw/Chiba/88/2002 by RNA LA PCR TM Kit (AMV) Ver.1.1 (TAKARA, Otsu, Japan) using random 9 mer and primer pairs EcoprMF (5'-ACA GAA TTC ACC ATG GGA GGA AAT GAA AGC TCG-3') and BglMR (5'-ACA AGA TCT TCA ACT GTA AGC CGG AGC GAC C-3') for prM, EcoprMF and BglER (5'-ACA AGA TCT TCA GGC ATG CAC ATT GGT CGC-3') for prME and EcoEF (5'-ACA GAA TTC ACC ATG CAA CGT GTG GTG TTT ACT ATT C-3') and BglER for E. Amplified cDNAs were cloned in the EcoRI-BglII site of pCAGGS [15] . The resultants were named as pCAG-prM, pCAG-E and pCAG-prME, respectively. Then, 293T cells were transfected with expression plasmids using Lipofectamine TM LTX and Plus TM Regent (Invitrogen, Carlsbad, CA, U.S.A.). As the result, all MAbs recognized prME protein and co-expressed prM and E, and seven recognized E protein alone and none recognized prM protein alone ( Table 1 ). The previous study indicates that the prM protein assists in the proper folding of E protein [7] . Therefore, the other eleven MAbs may recognize the conformational epitope in the presence of prM protein. Furthermore, western blot analysis using lysate of JEV/sw/Chiba/88/2002 infected Vero cells was carried out, resulting that three MAbs (3-1A5, 3-2D6 and 3-3B10) recognized a molecular mass of 50 kilodalton by western blot analysis under non-reducing condition ( Table 1) . This result also supported that all of our established MAbs did not react with linear epitope and recognized conformational epitope of E protein.
To determine the binding ability to purified vaccine antigen, Beijing 01 (genotype III), ELISA was carried out according to our previous report [21] . Fifteen MAbs showed significant reactivity (Absorbance >1.0), while three MAbs (1-1A7, 3-1C2 and 4-3E8) showed no or less reactivity (Absorbance <1.0) ( Table 1 ). These results indicated that most of the MAbs may be applicable for development of tools for JEV antibodies detection, such as competitive ELISA using purified vaccine antigen.
PRNT was performed to determine the virus-neutralization (VN) activity of ascites of each MAb to JEV. As the result, two MAbs (7E5 and 3-3H8) showed significant VN activity to both JEV/sw/Chiba/88/2002 and JaOH0566. Furthermore, to identify the epitope recognized by these MAbs, escape mutants, 7E5 mar Chiba, 3-3H8 mar Chiba and 7E5 mar JaOH0566 were selected by harvesting JEV in the presence of MAb 7E5 or 3-3H8, and amino acid sequences of capsid, prM and E were compared between parent strains and escape mutants. As the result, only one amino acid change was identified in the E proteins of 7E5 mar Chiba and 3-3H8 mar Chiba at E52 (Gln→His), and two amino acid changes were identified on the E protein of 7E5 mar JaOH0566 at E52 (Gln→His) and E276 (Ser→Arg) ( Table 2 ). Based on these sequence analyses of escape mutants, MAbs 7E5 and 3-3H8 recognized the domain I-II hinge region of E protein, which has been previously described as an important neutralizing epitope for JEV [5, 6, 8, 12] . These results confirmed that the domain I-II hinge region of E protein recognized by these MAbs is a major target of VN antibody.
To (Table 3 ). One MAb (3-1D7) recognized all of examined JEV, MVEV and WNV, suggesting that 3-1D7 might be specific for JEV serocomplex (Table  3 ). These JEV-specific MAbs and cross-reactive MAbs may be useful for detection of flaviviruses and may be applicable for differentiation of JEV infection from other flavivirus infection by immunohistochemistry and competitive ELISA.
In conclusion, these MAbs must be useful for further development of diagnostic methods of flavivirus infection.
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IFA was performed using 100-fold diluted mouse ascites.
